Review and Analysis

We analyze your child or patient’s clinical data to understand how their rare disorder impacts them, and presents challenges in their daily life. Our reports can be used to guide further treatment, or adopt new approaches to treating the underlying rare disorder. Our approach broadly encompasses the following steps:

OUR APPROACH

DATA COLLECTION

The first step is to collect data related to the rare disease, including information on symptoms, medical history, and family history.

DATA PREPROCESSING

The collected data is preprocessed, which involves cleaning the data, removing duplicates, and handling missing values.

DESCRIPTIVE ANALYSIS

A descriptive analysis of the data is carried out, which involves summarizing and visualizing the data to gain an understanding of the disease's characteristics.

EXPLORATORY ANALYSIS

An exploratory analysis is completed to identify patterns, trends, and relationships in the data. This can involve data mining techniques such as clustering, association rule mining, and decision trees.

MACHINE LEARNING

Machine learning algorithms can be used to analyze the data and identify predictive models that can be used to diagnose the disease.

INTEGRATION WITH DATABASES

Data from other sources such as genetic data, clinical trials, and research articles can be integrated with the clinical data to gain a more comprehensive understanding of the rare disease.

What you get

Our Rare Disease Consulting Review and Analysis service is designed to provide comprehensive insight into a child or patient's medical history. We provide an in-depth review of their clinical record, including test results, symptom development, and health evaluations. Our review culminates in a detailed summary report with specific recommendations for trials or further approaches that should be explored.

Our reports are typically used by clinicians who are struggling to maintain patients on successful treatment regimens. We make use of the underlying molecular biology of rare diseases provided in research and clinical studies, to evaluate current and future treatment approaches and provide insights into their potential benefits for children with rare diseases.